Harvard Health Experts and Contributors

Maria Mavrikaki, PhD, studied psychology and neuroscience at the University of Crete in Greece. After obtaining her PhD, she pursued a postdoctoral research fellow position at The Scripps Research Institute in Florida, where she utilized genetic mouse models to study mechanisms underlying motivation for food. She then pursued a postdoctoral research fellowship and an assistant neuroscientist position at McLean Hospital, where she studied neurobiological mechanisms underlying prescription opioid addiction. Dr. Mavrikaki is currently staff scientist in Dr. Frank Slack’s lab at Beth Israel Deaconess Medical Center. Since March 2017, she is also an instructor in psychiatry at Harvard Medical School. Her ongoing research assesses the role of small molecules called microRNAs in opioid addiction.

Dr. Ann Partridge is a professor of medicine at Harvard Medical School. She is vice chair of medical oncology and director of the Adult Survivorship Program at Dana-Farber Cancer Institute and Brigham and Women’s Hospital, where she also leads the Program for Young Women with Breast Cancer. As a medical oncologist and clinical and health services researcher, she has sought to improve the care and outcomes of patients with cancer by conducting research and by developing innovative clinical programming. Her research focuses on communications with cancer survivors; risk perceptions; decision-making and quality of life; behavioral aspects of cancer care, including adherence with anticancer therapy; age and race disparities in breast cancer outcomes; understanding and intervening to improve survivorship care; long-term effects of cancer and cancer treatment; and the unique disease and issues facing young women with breast cancer. Her main focus in recent years is younger women with breast cancer. She co-founded and directs the Program for Young Women with Breast Cancer. This novel program aims to improve care and health outcomes in young women with breast cancer at Dana-Farber, throughout New England, and beyond. In light of this highly successful program, Dr. Partridge was selected to lead the Adult Survivorship Program to enhance care and programming for the growing population of cancer survivors. Dr. Partridge is principal investigator for the Young Women’s Breast Cancer Study (YWS), a multi-institutional cohort of young women with breast cancer. The study enrolled over 1,300 women age 40 and younger at diagnosis. Dr. Partridge also serves in numerous leadership roles nationally and internationally. She is co-chair of the Breast Committee of the Alliance for Clinical Trials in Oncology, chair of the scientific program committee for American Society of Clinical Oncology (ASCO) 2018, and co-chair of the biennial ESMO-ESO sponsored Breast Cancer in Young Women Conference. She served as chair of the Centers for Disease Control and Prevention’s Advisory Committee on Breast Cancer in Young Women from 2010 to 2017. She has received numerous awards and grants, including a Champions of Change award from the White House, an ASCO Improving Cancer Care Grant, and the Edward J. Benz Jr. Award for Advancing the Careers of Women Faculty. After graduating from Georgetown University, Dr. Partridge received her medical degree from Cornell University Medical College, pursued an internal medicine residency at the Hospital for the University of Pennsylvania, and completed a medical oncology and hematology fellowship at Dana-Farber/Partners CancerCare. She earned a master of public health degree at the Harvard T.H. Chan School of Public Health.

Michelle Dossett, MD, PhD, MPH is an assistant physician and clinical researcher at the Benson-Henry Institute for Mind Body Medicine at Massachusetts General Hospital and an Assistant Professor of Medicine at Harvard Medical School. She board-certified in both internal medicine and integrative medicine. She received her MD and PhD in immunology from the University of Washington in Seattle, Washington. She completed her internship and residency in internal medicine and research fellowship in complementary and integrative medicine at Beth Israel Deaconess Medical Center. During her fellowship she received a MPH degree from the Harvard School of Public Health. Dr. Dossett is also a certified Ananda Yoga (RYT 200), restorative yoga, and meditation teacher. Dr. Dossett’s research interests include mind body medicine, the patient-clinician relationship, and clinician well-being. 

Kristina Liu, MD, MHS, is a dermatologist at Brigham and Women’s Hospital, where she serves as the director of the vitiligo clinic and director of dermatology simulation education. She received her medical degree and masters in health science from Yale School of Medicine, and completed her residency at the Harvard Combined Dermatology Program, where she served as chief resident. Her clinical and research interests include laser and cosmetic dermatology, pigmentary disorders of the skin, and medical education.

Kimberly Blumenthal, MD, MSc is an Allergist/Immunologist and drug allergy researcher at Massachusetts General Hospital and Assistant Professor of Medicine at Harvard Medical School.  She is also the Director of Allergy/Immunology Clinical Epidemiology Research within the Division of Rheumatology Allergy and Immunology, the Quality and Safety Officer for Allergy at the Edward P. Lawrence Center for Quality and Safety, and the Quality Director for Allergy/Immunology.  Dr. Blumenthal performs drug allergy research that uses methods of epidemiology, informatics, economics, and decision science.  Her research is funded by the NIH and foundations, including the American Academy of Allergy, Asthma, and Immunology Foundation and CRICO, the risk management foundation.  Dr. Blumenthal is recognized nationally for having created innovative approaches to the evaluation of penicillin and cephalosporin antibiotic allergies in the hospital that have since been adopted by other hospitals throughout the US and internationally, broadly referenced, and incorporated into expert recommendations. Dr. Blumenthal graduated from Columbia University with a BA in Economics.  She studied medicine at Yale University School of Medicine, which she completed in 2009, before training at the Massachusetts General Hospital for Internal Medicine and Allergy and Immunology. She completed a Master of Science in Clinical Epidemiology at the Harvard T.H. Chan School of Public Health in 2017.

Molly A. Wanner, M.D. is a board-certified dermatologist and an Instructor in Dermatology at Harvard Medical School. She practices at MGH’s Dermatology Laser and Cosmetic Center, one of the leading laser and cosmetic centers in the world.  Dr. Wanner received her medical degree from Columbia University College of Physicians and Surgeons, where she was inducted into the Alpha Omega Alpha Honor Society. She completed her dermatology residency at New York Presbyterian Hospital where she served as Chief Resident in her last year. Afterwards, she completed a clinical and research fellowship at the Wellman Center of Photomedicine, Massachusetts General Hospital.  Professionally, she is a member of several associations including the American Academy of Dermatology, American Society of Dermatologic Surgery, Women’s Dermatologic Society, and American Society of Laser Surgery and Medicine. She has co-authored several medical publications; is an invited guest speaker, and is frequently used a clinical expert source for news articles on lasers and light therapy such as cellulite and removal. Her expertise includes acne treatments, general dermatology, chemical peels. dermatologic surgery, cosmetic dermatology, fillers, facial rejuvenation, laser hair removal, laser of brown spots, blood vessels (red spots), and removal of spider veins.

Dr. Neera Nathan is a dermatologist and researcher at Massachusetts General Hospital and Lahey Hospital and Medical Center. Her clinical and research interests include dermatologic surgery, cosmetic dermatology, and laser medicine. She is part of the teaching faculty at Harvard Medical School, where she contributes to resident physician education.

David A. Shaye, MD, MPH, is a dual board-certified facial plastic & reconstructive surgeon at Massachusetts Eye and Ear and an instructor at Harvard Medical School. His practice includes rhinoplasty, aging face surgery, skin cancer reconstruction, and facial reconstruction after trauma. Dr. Shaye is active in the field of global surgery, which focuses on delivering surgical services to areas with limited resources. He is a volunteer with Doctors Without Borders, where he performs pediatric facial reconstruction.

Daniel L. Hall, PhD, is a licensed clinical health psychologist, Harvard Medical School integrative medicine research fellow, and a clinical fellow in psychology in the department of psychiatry at Massachusetts General Hospital (MGH). He works with clinical research teams at the MGH Behavioral Medicine program, the Benson-Henry Institute for Mind Body Medicine, the MGH Cancer Center, and the division of general medicine at Beth Israel Deaconess Medical Center. Dr. Hall’s research examines how medical patients experience and cope with uncertainty and stress arising from cancer and other chronic illnesses. He is currently testing a multimodal mind-body intervention to help ease fear of cancer recurrence.

James Michael Richter, MD, is a Physician at the Massachusetts General Hospital and Associate Professor of Medicine, Harvard Medical School in Boston, Massachusetts. He received his undergraduate degree from The University of Texas at Austin and Medical and Masters Degree from the University of Texas, Southwestern Medical School. He completed a residency in Internal Medicine and later a clinical and research fellowship in gastroenterology at the Massachusetts General Hospital and Harvard Medical School. He is a fellow of the American College of Physicians. Dr. Richter practices consultative and endoscopic gastroenterology. Dr. Richter has an established interest in healthcare systems development and quality management, infectious, and inflammatory enteric diseases. He served as a Trustee of the Partners Community Healthcare; the community network that is a part of the Partners HealthCare System and Trustee of the Massachusetts General Hospital. He was Medical Director of the Massachusetts General Physicians Corporation and its successor, the Massachusetts General Physicians Organization between 1992 and 2002. There he chaired the Managed Care, Medical Management, Medical Policy Committees and Clinical Performance Management Task Force. He was Chief Medical Officer of the Caritas Christi Health Care System from 2002 through 2004. Dr. Richter served as a member of the Baldrige National Quality Award Board of Examiners and the Massachusetts Medical Society Information Technology and Quality of Care Committees. He is recently the chair of the Society for General Internal Medicine National Clinical Practice Committee which is responsible for quality of care, practice management, and applications of clinical information technology. He currently serves on the advisory committee to CMS developing the criteria for episodes of care for MIPS and MACRA. He continues to have an active leadership role in medical management, safety and quality of care improvement at the Massachusetts General Hospital. His research interests include the effectiveness of care of the adult patient with digestive disease, screening for colorectal cancer, quality management in healthcare and healthcare systems development and improvement. He has contributed over 180 original papers and chapters to the medical literature.

Marwa Ahmed, MD, MS, is a sports medicine specialist at Massachusetts General Hospital and clinical instructor at Harvard Medical School. She also serves as medical director of the Spaulding Rehabilitation Network’s Brighton outpatient center and sports medicine program. With a background in human genetics and training in integrative medicine, she brings a unique understanding and approach to diagnosis, treatment, and prevention of sports injuries. Dr. Ahmed’s treatment philosophy incorporates and optimizes an individual’s nutritional status and lifestyle to cultivate and promote tissue healing, prevent injury, and enhance performance. Dr. Ahmed’s research focuses on the emerging field of sports genomics.

Mark D. Benson, M.D., Ph.D. is the Director of Preventive Cardiology at Beth Israel Deaconess Medical Center (BIDMC). He is also a basic and translational researcher in the field.  Dr. Benson received his B.A. in biological sciences from Columbia University and his M.D. and Ph.D. in pharmacology from the University of Michigan. He completed his residency training in internal medicine at the University of Michigan, his fellowship training in cardiology at Brigham and Women’s Hospital, and his post-doctoral training in multi-omics research at BIDMC. Dr. Benson is a principal investigator at the CardioVascular Institute at BIDMC. His laboratory’s interests are focused on applying emerging metabolomics, proteomics, and genomics technologies to detect signatures of small molecules in blood that may be used to predict an individual’s future risk of developing cardiovascular disease. The ultimate goal of this research is to identify novel biomarkers and pharmacological targets that may improve preventive cardiovascular disease therapy.

Paul Rizzoli, MD, is board-certified in Internal Medicine, Neurology and Headache Medicine. He is the Clinical Director of the Graham Headache Center at the Brigham and Women’s/ Faulkner Hospital in Boston, Massachusetts. Begun in 1999 and affiliated with the Harvard Medical School, it is one of the largest UCNS-accredited training programs in Headache Medicine in the United States. This academic headache center, located on the Faulkner Hospital campus, has as its mission to re-establish the Faulkner’s longstanding reputation for excellence in headache care and to carry on the legacy of Dr. John Graham, an early headache pioneer. The center is known for excellence in headache management, research and for clinical training in Headache Medicine.

Susan Abookire, BSEE, MD, MPH, FACP, an assistant professor at Harvard Medical School, is a senior executive with 20 years’ experience leading healthcare organizations. She has served as chief medical officer, system chief quality officer, and past chair of quality and patient safety at Mount Auburn Hospital. Dr. Abookire began her career as an electrical engineer in aviation systems. A graduate of Harvard Medical School, Dr. Abookire trained at Brigham and Women’s Hospital and practices internal medicine. She received a master’s degree from the Harvard School of Public Health and has taught nationally and internationally on patient safety, high reliability, and systems design. Dr. Abookire also enjoys being a forest therapy guide.

David J. Ramsey, MD, PhD, MPH, is currently the Director of Ophthalmic Research at the Lahey Hospital & Medical Center, a part of Beth Israel Lahey Health. As a specialist in retinal disease, he performs surgery and sees patients in Peabody and Burlington, MA. Dr. Ramsey received his M.D. and Ph.D. degrees from the University of Illinois at Chicago College of Medicine in 2008. He completed his residency in Ophthalmology at the Wilmer Eye Institute of the Johns Hopkins School of Medicine (2009-2012) and afterwards a combined medical/surgical fellowship in vitreoretinal diseases at the Massachusetts Eye and Ear Infirmary (2012-2014). His research focuses on the prevention and detection of retinal diseases such as diabetes, macular degeneration, and glaucoma.

Nicole J. LeBlanc is a doctoral candidate in clinical psychology at Harvard University, where she conducts research on the association between social factors and the development and maintenance of emotional disorders. She is also a clinical fellow in the department of psychology at Massachusetts General Hospital, where she is completing clinical and research training with the Cognitive Behavioral Therapy Program and the Center for Anxiety and Traumatic Stress Disorders. Her clinical interests include empirically-supported treatments for anxiety and traumatic stress disorders. She is a member of the Association for Behavioral and Cognitive Therapies (ABCT) and the Anxiety and Depression Association of America (ADAA).

Tsuyoshi Kaneko, MD, is a cardiac surgeon at Brigham and Women’s Hospital (BWH) and an assistant professor of surgery at Harvard Medical School. Dr. Kaneko received his medical degree from Keio University School of Medicine in Tokyo. He then completed three residency programs: one at Keio University, another in surgery at The University of Texas Health Science Center at Houston and the third in cardiothoracic surgery residency at BWH. He also completed a cardiothoracic surgery fellowship at BWH. He is board certified in general surgery. He specializes in endovascular approaches in cardiac surgery, including transcatheter aortic valve replacements—a catheter-based, minimally invasive surgical procedure for high-risk patients diagnosed with severe aortic stenosis—and thoracic endovascular aortic aneurysm repairs for thoracic aortic aneurysms. Dr. Kaneko also specializes in open aortic surgery and minimally invasive valve surgeries utilizing smaller incisions. His research focuses on the clinical outcomes of aortic and valvular disease.

Pinak B. Shah, MD is the Director of the Cardiac Catheterization Laboratory and Director of the Interventional Cardiology Training Program at Brigham and Women’s Hospital. His clinical interests include catheter based therapies for the treatment of valvular and structural heart disease. He directs the interventional arm of the Brigham and Women’s Structural Heart Team and is a high volume operator in the areas of trans-catheter aortic valve replacement (TAVR), Mitra-Clip, and a variety of other procedures. He is the site principal investigator for numerous clinical trials evaluating novel devices for the treatment of structural heart conditions and he has authored and co-authored numerous publications in this area. 

Raymond Chung, MD is the Director of Hepatology and Liver Center at Massachusetts General Hospital and a Associate Professor of Medicine at Harvard Medical School. Dr. Chung completed his B.A. at Harvard College and his MD from Yale University School of Medicine. He completed a residency in Internal Medicine and a fellowship in Gastroenterology and Hepatology at the Massachusetts General Hospital.  Dr. Chung’s focus has been fundamental and translational research in HCV infection.  Major focus of his research has been elucidating the basis for the observed accelerated liver disease pathogenesis in HCV-HIV coinfection.  In this regard his research has made important contributions to the current understanding of hepatic pathogenesis of coinfection.

I received my undergraduate and medical degree from Boston University. I then completed a neurology residency at the University of Pittsburgh, followed by a dementia and behavioral neuroscience fellowship at the University of California, Los Angeles. I am board certified in Neurology. I am currently the Director of Clinical Trials at the Center for Alzheimer Research and Treatment at Brigham and Women’s Hospital; Associate Neurologist at Brigham and Women’s Hospital; Assistant in Neurology at Massachusetts General Hospital; and Associate Professor of Neurology at Harvard Medical School. Over the past 17 years, I have focused on improving the clinical care of patients with Alzheimer’s disease (AD) and related conditions, in conjunction with clinical research in AD. Over the past 14 years, I have been site principal investigator for 14 clinical trials and 4 observational imaging studies in AD and am currently the site principal investigator for the Alzheimer’s Disease Neuroimaging Initiative (ADNI) 3 and the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) trial. My NIH-funded research has focused on clinical correlates of instrumental activities of daily living and neuropsychiatric symptoms with amyloid, tau, and FDG PET, structural and resting-state functional MRI, and CSF biomarkers across the early AD spectrum. More recently, I have been developing novel sensitive performance-based instrumental activities of daily living tests for early-stage AD. 

Jessica Allegretti, MD, MPH, graduated from Cornell University in Ithaca New York, and The Miller School of Medicine at the University of Miami in Miami, Florida. She was trained in internal medicine at Massachusetts’s General Hospital and completed her gastroenterology fellowship training at Brigham and Women’s Hospital. She later went on to receive a Master of Public Health degree from the Harvard School of Public Health. Currently she is an attending gastroenterologist at the Brigham and Women’s Hospital Crohn’s and Colitis Center, where she also serves as the center’s Director of Clinical Trials. In addition to her clinical responsibilities, Dr. Allegretti is the director of the fecal microbiota transplant program at Brigham and Women’s Hospital. She is currently leading several clinical trials investigating the use of fecal transplantation in several chronic diseases such as Inflammatory Bowel Disease, Primary Sclerosing Cholangitis and obesity. Additionally, Dr. Allegretti’s lab focuses on investigating the mechanisms of recurrent clostridium difficile infections.

Allan Walker is a Professor of Pediatrics and the Conrad Taff Professor of Nutrition Emeritus at Harvard Medical School (HMS) and Professor of Nutrition at the Harvard School of Public Health. He is the Chairman of the Division of Nutrition and an Investigator in the Mucosal Immunology and Biology Laboratory at the Massachusetts General Hospital for Children (MGHfC). He re-established Nutrition as a discipline at Harvard Medical School and now coordinates clinical and basic research projects in nutrition at HMS and its teaching hospitals. His research interests include defining the role of initial bacterial colonization in the development of intestinal host defense and determining the protective effects of breastfeeding in the prevention of disease in neonates.

Judy Nee, MD is a gastroenterologist at Beth Israel Deaconess Medical Center and an assistant professor at Harvard Medical School. She serves as co-director of the GI Motility Lab at Beth Israel. She specializes in GI motility disorders and functional GI diseases such as irritable bowel syndrome, chronic diarrhea, constipation as well as movement disorders of esophagus.

Kevin R. Loughlin, MD, MBA, received an AB from Princeton University, MD from New York Medical College, MBA from Boston University, and MA (honorary) from Harvard University. He practiced urology at Brigham and Women’s Hospital for 35 years, receiving an AUA research award while in training. He received the Alumni Medal of Honor from New York Medical College, the Lifetime Achievement Award from the New England Section of the AUA, and the Distinguished Service Award from the American Urological Association. He received the faculty teaching award on three occasions. He was a trustee of the American Board of Urology and a member of the board of directors of the American Urological Association. He has published over 250 articles in the medical literature, has been an author or editor of 12 books, and has served on multiple medical journal editorial boards.

Emma Davies, MD, has a broad-base of clinical interests to effectively manage patients with corneal and lenticular pathology. She is specialized in complex cataract surgery, partial thickness corneal transplantation including Descemet Membrane Endothelial Keratoplasty (DMEK) and Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), and refractive surgery. As a full-time member of the Cornea and Refractive Surgery Service at Mass. Eye and Ear, she offers exceptional, personalized, and detailed care both in the clinical and surgical settings. She has practices at the Mass. Eye and Ear Main Campus, Mass. Eye and Ear Longwood Campus, and Mass. Eye and Ear Waltham sites.    Dr. Davies earned her bachelor of science in biology with a concentration in marine biology at Duke University. She fulfilled an honors thesis with research in the chemical and visual orientation of estuarine crustaceans. She completed her medical degree at the University of Pennsylvania School of Medicine. Dr. Davies was granted a Clinical Neuroscience Research Grant to complete research in ganglion cell loss after optic neuritis in multiple sclerosis patients. She was awarded the University of Pennsylvania Ophthalmology Excellence Award at medical school graduation for her work. She completed her medical internship at the Pennsylvania Hospital in the University of Pennsylvania Health Care System. Dr. Davies went on to join the Harvard Ophthalmology residency program at Mass. Eye and Ear. She was awarded the Best Resident Research Award in Cornea and Refractive Surgery at Mass. Eye and Ear for her work in changing trends in herpes zoster ophthalmicus (HZO) presentation. She continued at Mass. Eye and Ear for her fellowship in Cornea, Refractive Surgery, and External Diseases. She completed work in surgical outcomes for a variety of complex cataract surgery procedures, including scleral-fixated lens placement and cataract surgery in retinitis pigmentosa patients, and investigated predictive factors for corneal clearance after Descemet’s membrane stripping only for patients with Fuchs Endothelial Dystrophy. Dr. Davies brings cutting-edge diagnostic procedures and surgical techniques to her practice at Mass Eye and Ear. She trained with Dr. Pineda for complex cataract surgery techniques (including intra-scleral fixation of a lens after trauma or vitreoretinal surgery) and Dr. Veldman for DMEK techniques (including pre-loaded DMEK grafts) and is eager to continue to expand our advances in corneal and refractive surgery.     As a clinician scientist, Dr. Davies has published a number of studies regarding complex cataract surgery outcomes and techniques as well as the management of complicated corneal infections, including corneal ulcers, infections after keratoprosthesis, and herpes zoster ophthalmicus. She is the author of the corneal ulcer algorithm that has standardized care of corneal ulcers in the Mass. Eye and Ear Emergency Room. She has also published multiple studies regarding state-of-the-art treatments for Fuchs corneal dystrophy patients, particularly Descemet’s membrane stripping without endothelial keratoplasty (DWEK). She currently is studying rho kinase inhibitor impact on corneal clearance after DWEK.